Advanced Nanocarriers for Targeted Drug Delivery in Inflammation-Associated Diseases
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Drug Delivery and Controlled Release".
Deadline for manuscript submissions: 30 November 2026 | Viewed by 843
Special Issue Editors
Interests: polymeric nanoparticles; liposomes; drug delivery; controlled drug release; physical chemistry
Interests: biomaterial design; polyurethane synthesis; bioprinting; wound healing; drug delivery systems; multi-stimuli-responsive polymers; bioink design; cell culture; tissue modeling; inflammation modelling; hydrogels
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Chronic inflammation is a defining feature of many debilitating diseases, including autoimmune disorders, infectious diseases, neurodegenerative conditions, and cancer. The complexity of the inflammatory microenvironment and the presence of biological barriers present significant challenges to effective treatment. In recent years, however, advanced nanocarrier systems have emerged as a powerful tool for overcoming these limitations by enabling precise drug delivery to inflamed tissues while minimizing systemic side effects.
This Special Issue aims to showcase the latest developments in the design, characterization and application of nanocarriers engineered for targeted drug delivery in inflammation-associated diseases. The emphasis will be on innovative strategies to improve selectivity, enhance pharmacokinetics and enable controlled drug release in response to inflammatory signals. Examples include polymeric nanoparticles, liposomes, dendrimers, micelles and stimuli-responsive systems that exploit the unique pathophysiological features of inflamed tissues.
We invite original research articles, reviews and perspectives that explore multidisciplinary approaches integrating nanotechnology, materials science, pharmacology and biology. Contributions addressing translational challenges, safety, and regulatory aspects are also welcome. This special issue will advance our understanding of inflammation-targeted nanomedicine and guide the development of next-generation therapeutics.
Dr. Ana Laura López-Machado
Dr. Rossella Laurano
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- control release
- drug delivery systems
- inflammation-associated diseases
- liposomes
- micelles
- nanocarriers
- polymeric nanoparticles
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
